Inici › Insuficiència cardíaca › Virgínia › Richmond
Assaigs clínics de Insuficiència cardíaca a Richmond, VA
16 estudis de Insuficiència cardíaca busquen participants en centres de Richmond i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
ReclutantFase 3
- Research Site, Midlothian · a 11 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
ReclutantFase 3
- Richmond, VA Investigative Site 10069, Richmond
- Richmond, VA Investigative Site 10067, Richmond
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Reclutant
- Virginia Commonwealth University, Richmond
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
ReclutantEstudi observacional
- VCU Medical Center, Richmond
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutantFase 3
- Virginia Commonwealth University, Richmond
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Reclutant
- Richmond VA Medical Center, Richmond, VA, Richmond
Assessment of CCM in HF With Higher Ejection Fraction
Reclutant
- Bon Secours St. Mary's, Richmond
- Bon Secours St. Mary's, Richmond
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
ReclutantFase 3
- FIN-10093, Richmond, VA, Richmond
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
ReclutantFase 1/2
- Virginia Commonwealth University, Richmond
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
ReclutantFase 3
- Virginia Commonwealth University, Richmond
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Reclutant
- HCA Chippenham Medical Center, Richmond
His-Bundle Corrective Pacing in Heart Failure
Reclutant
- Virginia Commonwealth University, Richmond
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
ReclutantEstudi observacional
- Virginia Commonwealth University School of Medicine, Richmond
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
ReclutantFase 2/3
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Left vs Left Randomized Clinical Trial
Reclutant
- Virginia Commonwealth University, Richmond
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
ReclutantFase 4
- Virginia Commonwealth University, Richmond
Assaigs de Insuficiència cardíaca en altres ciutats
- New York City, NY51 estudis
- Boston, MA44 estudis
- Dallas, TX42 estudis
- Houston, TX36 estudis
- Cleveland, OH33 estudis
- Chicago, IL31 estudis
- Philadelphia, PA31 estudis
- San Francisco, CA29 estudis
- St. Louis, MO26 estudis
- Durham, NC26 estudis
- Kansas City, MO25 estudis
- Atlanta, GA25 estudis
Altres estudis a Richmond
- Càncer de mama26 estudis
- Càncer de pulmó de cèl·lules no petites25 estudis
- Càncer de pròstata19 estudis
- Càncer de pulmó14 estudis
- Càncer colorrectal13 estudis
- Malaltia cardiovascular13 estudis
- Malaltia hepàtica esteatòtica12 estudis
- Leucèmia mieloide aguda12 estudis
- Carcinoma de cèl·lules escamoses de cap i coll12 estudis
- Càncer metastàtic12 estudis
- Melanoma11 estudis
- Obesitat11 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.